CIK 0001727196
- Non-accelerated filer
Scholar Rock Holding Corp
Sign in to watch- Ticker
- SRRK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823750435
- Phone
- +1 857-259-3860
- Business address
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $11,999,922
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-25 | Marantz Jing L. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −2,100 | $39.25 | $82K | 76,130 |
| 2024-11-25 | Marantz Jing L. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −3,075 | $39.93 | $123K | 73,055 |
| 2024-11-25 | Marantz Jing L. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −200 | $40.72 | $8K | 72,855 |
| 2024-11-25 | Marantz Jing L. CHIEF MEDICAL OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −6,375 | 130,000 | ||
| 2024-11-22 | Marantz Jing L. CHIEF MEDICAL OFFICER | Exercise or conversion 10b5-1 | +2,145 | $8.59 | $18K | 75,000 |
| 2024-11-22 | Marantz Jing L. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −2,145 | $30.01 | $64K | 72,855 |
| 2024-11-22 | Marantz Jing L. CHIEF MEDICAL OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −2,145 | 136,375 | ||
| 2024-11-12 | Gilman Michael Director | Gift | −37,459 | 0 | ||
| 2024-11-12 | Gilman Michael Director | Gift | +37,459 | 50,959 | ||
| 2024-11-11 | Marantz Jing L. CHIEF MEDICAL OFFICER | Exercise or conversion 10b5-1 | +2,105 | $8.59 | $18K | 74,960 |
| 2024-11-11 | Marantz Jing L. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −2,105 | $30.00 | $63K | 72,855 |
| 2024-11-11 | Marantz Jing L. CHIEF MEDICAL OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −2,105 | 138,520 | ||
| 2024-10-08 | Myles Edward H COO & CFO | Exercise or conversion 10b5-1 | +37,187 | $10.00 | $372K | 198,275 |
| 2024-10-08 | Myles Edward H COO & CFO | Sale 10b5-1 | −37,187 | $34.90 | $1.3M | 161,088 |
| 2024-10-08 | Myles Edward H COO & CFO | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −37,187 | 47,813 | ||
| 2024-10-07 | AKKARAJU SRINIVAS Director | Sale 10b5-1 | −510,000 | $27.50 | $14.0M | 6,278,609 |
| 2024-10-07 | AKKARAJU SRINIVAS Director | Sale 10b5-1 | −510,000 | $30.00 | $15.3M | 5,768,609 |
| 2024-10-07 | AKKARAJU SRINIVAS Director | Sale 10b5-1 | −155,713 | $32.50 | $5.1M | 5,612,896 |
| 2024-10-07 | Myles Edward H COO & CFO | Exercise or conversion 10b5-1 | −206,240 | $13.83 | $2.9M | 367,328 |
| 2024-10-07 | Myles Edward H COO & CFO | Sale 10b5-1 | −111,972 | $25.61 | $2.9M | 255,356 |
Page 13 of 22 · 422 trades